§ 10-16-1313. Severability
If any provision of this part 13 or application thereof to any person or circumstances is judged invalid, the invalidity does not affect provisions or applications of this part 13 that can be given effect without the invalid provision or application, and to this end the provisions of this part 13 are declared severable. Source: […]
§ 10-16-1416. Repeal of Part
This part 14 is repealed, effective September 1, 2026. Before the repeal, the functions of the board are scheduled for review in accordance with section 24-34-104. Source: L. 2021: Entire part added, (SB 21-175), ch. 240, p. 1276, § 2, effective June 16.
§ 10-16-1401. Definitions
As used in this part 14, unless the context otherwise requires: “Advisory council” means the Colorado prescription drug affordability advisory council created in section 10-16-1409. “Affordability review” means an affordability review of a prescription drug performed by the board pursuant to section 10-16-1406. “All-payer health claims database” means the all-payer health claims database described in […]
§ 10-16-1402. Colorado Prescription Drug Affordability Review Board – Created – Membership – Terms – Conflicts of Interest
The Colorado prescription drug affordability review board is created in the division. The board is a body politic and corporate and is an instrumentality of the state. The board is an independent unit of state government, and the exercise by the board of its authority under this part 14 is an essential public function. The […]
§ 10-16-1403. Colorado Prescription Drug Affordability Review Board – Powers and Duties – Rules
To protect Colorado consumers from excessive prescription drug costs, the board shall: Collect and evaluate information concerning the cost of prescription drugs sold to Colorado consumers, as described in section 10-16-1405; Perform affordability reviews of prescription drugs, as described in section 10-16-1406; Establish upper payment limits for prescription drugs, as described in section 10-16-1407; and […]
§ 10-16-1404. Colorado Prescription Drug Affordability Review Board Meetings – Required to Be Public – Exceptions
The board shall hold its first meeting within six weeks after all of the board members are appointed and shall meet at least every six weeks thereafter to review prescription drugs; except that the chair may cancel or postpone a meeting if the board has no prescription drugs to review. The board is a state […]
§ 10-16-1405. Colorado Prescription Drug Affordability Review Board – Reports From Carriers and Pharmacy Benefit Management Firms Required – Confidential Materials
Beginning in the 2022 calendar year, for all prescription drugs dispensed at a pharmacy in this state and paid for by a carrier pursuant to a health benefit plan issued under part 2, 3, or 4 of this article 16 during the immediately preceding calendar year, including brand-name drugs, authorized generic drugs, biological products, and […]
§ 10-16-1406. Colorado Prescription Drug Affordability Review Board – Affordability Reviews of Prescription Drugs
The board may conduct affordability reviews of prescription drugs in accordance with this section. The board shall identify, for purposes of determining whether to conduct an affordability review, any prescription drug that is: A brand-name drug or biological product that, as adjusted annually for inflation, has: An initial wholesale acquisition cost of thirty thousand dollars […]
§ 10-16-1407. Colorado Prescription Drug Affordability Review Board – Upper Payment Limits for Certain Prescription Drugs – Rules – Severability
The board may establish an upper payment limit for any prescription drug for which the board has performed an affordability review pursuant to section 10-16-1406 and determined that the use of the prescription drug is unaffordable for Colorado consumers; except that the board may not establish an upper payment limit for more than twelve prescription […]
§ 10-16-1408. Colorado Prescription Drug Affordability Review Board – Appeals – Rules – Judicial Review
A person aggrieved by a decision of the board may appeal the decision within sixty days after the decision is made. The board shall consider the appeal and issue a final decision concerning the appeal within sixty days after the board receives the appeal. Not later than March 31, 2022, the board shall promulgate rules […]